REGENXBIO Inc. (RGNX) by event type
RGNX moves most on analyst downgrades — a median of -1.49% at 30 minutes across 14 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the RGNX overview →
How RGNX reacts across 5 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 2,656 of 2,717 | 19 | -1.33% | 32% | -2.34% |
| Analyst downgrades 2,486 of 2,603 | 14 | -1.49% | 36% | -1.08% |
| Coverage initiations 1,957 of 2,283 | 13 | -0.57% | 31% | +0.43% |
| Rating reiterations 3,190 of 3,522 | 94 | -0.35% | 43% | -0.49% |
| Price-target cuts 1,427 of 1,527 | 13 | -0.41% | 31% | -0.67% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 1 further class was observed with fewer than 10 measured events and is not published.
That’s how RGNX usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · Price-target cuts → · RGNX overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| AB Corporate Bond ETF (EYEG) | 700 | 0.00% | 44% |
| STEMLINE THERAPEUTICS (STML) | 697 | +0.08% | 51% |
| ALDER BIOPHARMACEUTICALS INC (ALDR) | 693 | -0.21% | 45% |
| DIGIRAD (DRAD) | 692 | 0.00% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.